Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

New drugs are improving treatment for hormone-related diseases in small pets.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.